Anakinra, A Recombinant Human IL-1 Receptor Antagonist for Neuroinflammation in HIV-1 Infection
Clinical trial NCT02527460 · TERMINATED
Trial details
- NCT number
- NCT02527460
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-17
- Primary completion
- 2018-03-02
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.